Systemic effects of interferons after oral administration in animals and humans.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  American Journal of Veterinary Research

• Publication date

  2005-12-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2460/AJVR.2005.66.164PMID 15691053
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human recombinant interferonalpha-2b for management of idiopathic recurrent superficial pyoderma in dogs: a pilot study.

  2004cited by this paper
• Treatment of inflammatory airway disease in young standardbreds with interferon alpha.

  2004cited by this paper
• Pigmented epidermal plaques in three dogs.

  2004cited by this paper
• Oral interferon beta-1a in relapsing-remitting multiple sclerosis: a double-blind randomized study

  2003cited by this paper
• Treatment of primary Sjögren's syndrome with low-dose human interferon alfa administered by the oromucosal route: combined phase III results.

  2003cited by this paper
• Oral interferon-α treatment of mice with cryoglobulinemic glomerulonephritis * ** *

  2002cited by this paper
• Cytokine modulators as novel therapies for asthma.

  2002cited by this paper
• Inhibitory effects of whole and parotid saliva on immunomodulators.

  2002cited by this paper
• Interleukin-10: a complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug.

  2002cited by this paper
• Molecular cloning of ADIR, a novel interferon responsive gene encoding a protein related to the torsins.

  2002cited by this paper
• Interleukin-10: A complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug.

  2002cited by this paper
• Induction of blood 2',5'-oligoadenylate synthetase activity in mice by gastric administration of ovine IFN-tau.

  2002cited by this paper
• Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled challenge trial.

  2002cited by this paper
• Oral interferon-alpha treatment of mice with cryoglobulinemic glomerulonephritis.

  2002cited by this paper
• Induction of Blood 2′,5′-Oligoadenylate Synthetase Activity in Mice by Gastric Administration of Ovine IFN-τ

  2002cited by this paper
• Innate immunity and its role against infections.

  2002cited by this paper
• Cellular Responses in Chickens Treated with IFN-α Orally or Inoculated with Recombinant Marek's Disease Virus Expressing IFN-α

  2001cited by this paper
• Ingested IFN- Preserves Residual Cell Function in Type 1 Diabetes

  2001cited by this paper
• Ingested IFN-α

  2001cited by this paper
• Cellular responses in chickens treated with IFN-alpha orally or inoculated with recombinant Marek's disease virus expressing IFN-alpha.

  2001cited by this paper
• Immunomodulation therapy for feline leukemia virus infection.

  2001cited by this paper
• Cytokines: Past, Present, and Future

  2001cited by this paper
• Chicken Interferon Type I Inhibits Infectious Bronchitis Virus Replication and Associated Respiratory Illness

  2001cited by this paper
• Induction of Tolerance to Recombinant Therapeutic Proteins

  2001cited by this paper
• Effect of oromucosal administration of IFN-alpha on allergic sensitization and the hypersensitive inflammatory response in animals sensitized to ragweed pollen.

  2001cited by this paper
• Bioactive factors in human milk.

  2001cited by this paper
• Oromucosal Interferon Therapy: Relationship Between Antiviral Activity and Viral Load

  2001cited by this paper
• Low-Dose Orally Administered Type I Interferon Reduces Splenic B Cell Numbers in Mice

  2001cited by this paper
• Ingested IFN-alpha: results of a pilot study in relapsing-remitting MS.

  2001cited by this paper
• Therapeutic relevance of altered cytokine expression.

  2001cited by this paper
• The immunological system in human milk: the past--a pathway to the future.

  2001cited by this paper
• Effect of Oromucosal Administration of IFN-α on Allergic Sensitization and the Hypersensitive Inflammatory Response in Animals Sensitized to Ragweed Pollen

  2001cited by this paper
• Ingested IFN-alpha preserves residual beta cell function in type 1 diabetes.

  2001cited by this paper
• Complex effects of interferon-alpha on the cytokine network in HIV infection--possible contribution to immunosuppression.

  2001cited by this paper
• Low-dose oral interferon-α in the treatment of chronic viral hepatitis type B: A double-blind, randomized, placebo-controlled, clinical trial

  2000cited by this paper
• Oral use of interferon therapy in cervical human papillomavirus infection.

  2000cited by this paper
• Peroral alpha-interferon therapy in HPV-lesions of the lower female genital tract: preliminary results.

  2000cited by this paper
• Modulation of the gastrointestinal tract of infants by human milk. Interfaces and interactions. An evolutionary perspective.

  2000cited by this paper
• Optimization of the Weck-Cel Collection Method for Quantitation of Cytokines in Mucosal Secretions

  2000cited by this paper
• Interferon α/β-mediated inhibition and promotion of interferon γ: STAT1 resolves a paradox

  2000cited by this paper
• Preliminary note on the use of interferon alpha by peroral route in HPV lesions.

  2000cited by this paper
• Clinical trial results on the use of a recombinant feline interferon-omega to protect Japanese pearl oysters Pinctada fucata martensii from akoya-virus infection.

  2000cited by this paper
• Interferon alpha/beta-mediated inhibition and promotion of interferon gamma: STAT1 resolves a paradox.

  2000cited by this paper
• New treatment of viral genital lesions with low dosage of interferon alpha by oropharyngeal absorption.

  2000cited by this paper
• Effects of interferon alpha administered by peroral route on lymphomonocytes' subpopulations of peripheral blood in healthy volunteers.

  2000cited by this paper
• Are chemokines essential or secondary participants in allergic responses?

  2000cited by this paper
• The Impact of the Ovulatory Cycle on Cytokine Production: Evaluation of Systemic, Cervicovaginal, and Salivary Compartments

  2000cited by this paper
• Ingested interferon-alpha prevents allograft islet transplant rejection.

  2000cited by this paper
• Oromucosal Interferon Therapy: Marked Antiviral and Antitumor Activity

  1999cited by this paper
• Low-Dose Oral Use of Human Interferon-alpha in Cancer Patients

  1999cited by this paper
• RANTES, Macrophage-Inhibitory Protein 1α, and the Eosinophil Product Major Basic Protein Are Released into Upper Respiratory Secretions during Virus-Induced Asthma Exacerbations in Children

  1999cited by this paper
• Oral Use of Interferon

  1999cited by this paper
• Suppression of Late Asthmatic Response by Low-Dose Oral Administration of Interferon-beta in the Guinea Pig Model of Asthma

  1999cited by this paper
• Interferon Action on Avian Viruses. I. Oral Administration of Chicken Interferon-alpha Ameliorates Newcastle Disease

  1999cited by this paper
• Reduction of Morning Stiffness and Improvement in Physical Function in Fibromyalgia Syndrome Patients Treated Sublingually with Low Doses of Human Interferon-alpha

  1999cited by this paper
• Interferon-alpha Upregulates Gene Expression of Aquaporin-5 in Human Parotid Glands

  1999cited by this paper
• Efficacy of Low-Dose Oral Use of Type I Interferon in Cytomegalovirus Infections In Vivo

  1999cited by this paper
• The Oropharyngeal Delivery of Interferons: Where Are We and Where Do We Need to Go?

  1999cited by this paper
• A multicenter, randomized, controlled trial of three preparations of low-dose oral alpha-interferon in HIV-infected patients with CD4+ counts between 50 and 350 cells/mm(3). Division of AIDS Treatment Research Initiative (DATRI) 022 Study Group.

  1999cited by this paper
• Oromucosal Interferon Therapy: Pharmacokinetics and Pharmacodynamics

  1999cited by this paper
• Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease.

  1999cited by this paper
• Low-Dose Oral Use of Interferon Inhibits Virally Induced Myocarditis

  1999cited by this paper
• Low-Dose Oral Administration of Interferon-alpha for the Treatment of Immune-Mediated Keratoconjunctivitis Sicca in Dogs

  1999cited by this paper
• Oral Use of Interferon-alpha Delays the Onset of Insulin-Dependent Diabetes Mellitus in Nonobese Diabetes Mice

  1999cited by this paper
• Quantification of Cytokines and Inflammatory Mediators in Samples of Nasopharyngeal Secretions with Unknown Dilution

  1999cited by this paper
• Treatment of Primary Sjogren's Syndrome with Low-Dose Natural Human Interferon-alpha Administered by the Oral Mucosal Route: A Phase II Clinical Trial

  1999cited by this paper
• Effects of Oral Administration of Interferon-alpha on Antibody Production in Mice with Induced Tolerance

  1999cited by this paper
• Oral Use of Interferon-alpha Stimulates ISG-15 Transcription and Production by Human Buccal Epithelial Cells

  1999cited by this paper
• Ingested interferon alpha induces Mx mRNA.

  1999cited by this paper
• Natural Human Interferon-alpha Administered Orally as a Treatment of Bovine Respiratory Disease Complex

  1999cited by this paper
• Oral-mucosal administration of IFN-alpha potentiates immune response in mice.

  1998cited by this paper
• IFN-alpha cream in the treatment of oral lichen planus.

  1998cited by this paper
• Lack of efficacy of low dose oral interferon alfa in symptomatic HIV-1 infection: a randomised, double blind, placebo controlled trial.

  1998cited by this paper
• Mechanisms of IL-6, IL-8, and GM-CSF release in nasal secretions of allergic patients after nasal challenge.

  1998cited by this paper
• Ingested interferon alpha suppresses type I diabetes in non-obese diabetic mice.

  1998cited by this paper
• Cytokines, Chemokines, and Colony-Stimulating Factors in Human Milk: The 1997 Update

  1998cited by this paper
• A Pilot Double-Blind, Randomized, and Placebo-Controlled Study of Orally Administered IFN-α-n1 (Ins) in Pediatric Patients with Measles

  1998cited by this paper
• Single-Blinded Controlled Trial of Low-Dose Oral IFN-α for the Treatment of Xerostomia in Patients with Sjögren's Syndrome

  1998cited by this paper
• Orally administered IFN-alpha acts alone and in synergistic combination with intraperitoneally administered IFN-gamma to exert an antitumor effect against B16 melanoma in mice.

  1998cited by this paper
• Orally Administered IFN-α Acts Alone and in Synergistic Combination with Intraperitoneally Administered IFN-γ to Exert an Antitumor Effect Against B16 Melanoma in Mice

  1998cited by this paper
• Single-blinded controlled trial of low-dose oral IFN-alpha for the treatment of xerostomia in patients with Sjögren's syndrome.

  1998cited by this paper
• Oral-Mucosal Administration of IFN-α Potentiates Immune Response in Mice

  1998cited by this paper
• Alpha-interferon inhibits the development of diabetes in NOD mice.

  1998cited by this paper
• Th1/Th2 cytokine expression in saliva of HIV-positive and HIV-negative individuals: a pilot study in HIV-positive individuals with oropharyngeal candidiasis.

  1998cited by this paper
• Low dose Oral Interferon Alpha 2a in HIV-1 Seropositive Patients: A Double-blind, Placebo-controlled Trial

  1998cited by this paper
• Ingested interferon α suppresses Type I diabetes in non-obese diabetic mice

  1998cited by this paper
• Association between interleukin-8 concentration in nasal secretions and severity of symptoms of experimental rhinovirus colds.

  1998cited by this paper
• Intranasal Administration of IFN-α/β Inhibits the Development of Visceral Tumor Metastases

  1997cited by this paper
• Effect of exposure to swine dust on levels of IL-8 in airway lavage fluid.

  1997cited by this paper
• Ingested IFN-alpha has biological effects in humans with relapsing-remitting multiple sclerosis.

  1997cited by this paper
• Low-Dose Oral Type I Interferons Reduce Early Virus Replication of Murine Cytomegalovirus In Vivo

  1997cited by this paper
• The biology of the immune system.

  1997cited by this paper
• Oral feeding of interferon τ can prevent the acute and chronic relapsing forms of experimental allergic encephalomyelitis

  1997cited by this paper
• Ingested IFN-α has biological effects in humans with relapsing-remitting multiple sclerosis

  1997cited by this paper
• Intranasal administration of IFN-alpha/beta inhibits the development of visceral tumor metastases.

  1997cited by this paper
• Suppression of Adjuvant Arthritis in Rats by Oral Administration of Type II Collagen in Combination with Type I Interferon

  1996cited by this paper
• Oral administration of IFN-alpha is superior to subcutaneous administration of IFN-alpha in the suppression of chronic relapsing experimental autoimmune encephalomyelitis.

  1996cited by this paper
• Oral Administration of IFN-α is Superior to Subcutaneous Administration of IFN-α in the Suppression of Chronic Relapsing Experimental Autoimmune Encephalomyelitis

  1996cited by this paper
• Cytokines in human milk: Properties and potential effects upon the mammary gland and the neonate

  1996cited by this paper
• Changes in airway inflammatory cell populations in standardbred racehorses after interferon-alpha administration.

  1996cited by this paper

• Plant Systems as Platforms for the Production of Interferon Alpha and its Application

  2025cites this paper
• A pH-triggered self-releasing humic acid hydrogel loaded with porcine interferon α/γ achieves anti-pseudorabies virus effects by oral administration

  2024cites this paper
• Recombinant porcine interferon cocktail delays the onset and lessens the severity of African swine fever.

  2023cites this paper
• Transient Co-Expression of Bioactive Murine Interferon-Gamma and HBsAg in Tobacco and Lettuce Leaves

  2023cites this paper
• Interferons-α and -γ in clinical veterinary practice in the prevention and treatment of infectious diseases in cattle and pigs (review)

  2022cites this paper
• Management of Severe Oral Inflammatory Conditions in Dogs and Cats.

  2022cites this paper
• Anticancer Effects of Sublingual Type I IFN in Combination with Chemotherapy in Implantable and Spontaneous Tumor Models

  2021cites this paper
• Therapeutic and Prophylactic Use of Oral, Low-Dose IFNs in Species of Veterinary Interest: Back to the Future

  2021cites this paper
• Can Unconventional Immunomodulatory Agents Help Alleviate COVID-19 Symptoms and Severity?

  2020cites this paper
• The Role of BDNF on Aging-Modulation Markers

  2020cites this paper
• An Update on Feline Chronic Gingivostomatitis

  2020cites this paper
• Could Unconventional Immunomodulatory Agents Help Alleviate COVID-19 Symptoms and Severity?

  2020cites this paper
• The effect of interferon alpha administration on cytokine levels in sheep

  2020cites this paper
• Bacteria-related Events and the Immunological Response of Onset and Relapse Adult Crohn’s Disease Patients

  2018cites this paper
• Diagnosis and treatment of a novel papillomavirus in a North American porcupine (Erethizon dorsatum)

  2018cites this paper
• Intestinal Epithelial Cells Regulate Gut Eotaxin Responses and Severity of Allergy

  2018cites this paper
• Cytokine responses in campylobacteriosis: Linking pathogenesis to immunity.

  2018cites this paper
• Shelf life of diluted human interferon-α for veterinary clinical use.

  2017cites this paper
• Antiviral activity of ovine interferon tau 4 against foot‐and‐mouth disease virus

  2017cites this paper
• ow-dose oral interferon modulates expression of inflammatory and utoimmune genes in cattle tephen

  2016cites this paper
• Immunoprophylaxis in intensive farming systems: the way forward.

  2016cites this paper
• Treatment with low-dose cytokines reduces oxidative-mediated injury in perilesional keratinocytes from vitiligo skin.

  2015cites this paper
• PIG TONSIL CELLS AS A MODEL TO EVALUATE ORAL, LOW-DOSE CYTOKINE TREATMENTS

  2014cites this paper
• Oral and subcutaneous therapy of canine atopic dermatitis with recombinant feline interferon omega.

  2014cites this paper
• A Double-Blind Randomized Controlled Study to Evaluate the Efficacy of Low-Dose Oral Interferon-Alpha in Preventing Hepatitis C Relapse

  2014cites this paper
• Protection from pulmonary tissue damage associated with infection of cynomolgus macaques by highly pathogenic avian influenza virus (H5N1) by low dose natural human IFN-α administered to the buccal mucosa

  2014influential citation
• Antitussive Drugs—Past, Present, and Future

  2014cites this paper
• A pig tonsil cell culture model for evaluating oral, low-dose IFN-α treatments.

  2014cites this paper
• Immune Control of PRRS: Lessons to be Learned and Possible Ways Forward

  2014cites this paper
• Topical biological agents targeting cytokines for the treatment of dry eye disease

  2013cites this paper
• Immunoprotection of grass carp (Ctenopharyngodon idella) with recombinant interferon (rCiIFN) against GCHV infection

  2013cites this paper
• Oral Administration of Interleukin-10 and Anti-IL-1 Antibody Ameliorates Experimental Intestinal Inflammation

  2013cites this paper
• Local gene therapy and the identification of therapeutic targets in Sjögren’s syndrome

  2012cites this paper
• The Effects of Simvastatin or Interferon-α on Infectivity of Human Norovirus Using a Gnotobiotic Pig Model for the Study of Antivirals

  2012cites this paper
• Isolation and culture of pig tonsil lymphocytes.

  2012cites this paper
• Feline herpesvirus-1: Ocular manifestations, diagnosis and treatment options

  2012cites this paper
• Metabolic stress and inflammatory response in high-yielding, periparturient dairy cows.

  2012cites this paper
• Assessment of Bioactivity of a Recombinant Chicken Interferon-Gamma Expressed Using a Baculovirus Expression System

  2011cites this paper
• Feline Herpesvirus-1

  2011cites this paper
• Low-Dose Interferon Type I Treatment Is Effective Against H5N1 and Swine-Origin H1N1 Influenza A Viruses In Vitro and In Vivo

  2011cites this paper
• Comparative efficacy of a recombinant feline interferon omega in refractory cases of calicivirus-positive cats with caudal stomatitis: A randomised, multi-centre, controlled, double-blind study in 39 cats

  2011cites this paper
• Low-dose oral interferon α possibly retards the progression of idiopathic pulmonary fibrosis and alleviates associated cough in some patients

  2010cites this paper
• Cytokines in Sjögren's syndrome: potential therapeutic targets

  2010cites this paper
• Evidence for association between sarcoidosis and pulmonary embolism from 35-year record linkage study

  2010cites this paper
• Constitutive expression of interferons in swine leukocytes.

  2010cites this paper
• Oromucosal Administration of Interferon to Humans

  2010influential citation
• UvA-DARE ( Digital Academic Repository ) Cytokines in Sjogren ' s syndrome : potential therapeutic targets

  2010cites this paper
• Increased mRNA expression of interferon-induced Mx1 and immunomodulation following oral administration of IFN-α2b-transformed B. longum to mice

  2010cites this paper
• Immune system response to stress factors

  2009cites this paper
• Metabolic changes in dairy cows induced by oral, low-dose interferon-alpha treatment.

  2009cites this paper
• Preliminary studies on the effects of orally-administered Transforming Growth Factor-beta on protozoan diseases in mice.

  2009cites this paper
• Low dose oral administration of cytokines for treatment of allergic asthma.

  2009cites this paper
• Effects of Interferon-α on the Inflammatory Response of Swine Peripheral Blood Mononuclear Cells

  2009cites this paper
• Immunostimulatory effects of natural human interferon-alpha (huIFN-alpha) on carps Cyprinus carpio L.

  2009cites this paper
• Heterologous expression of synthetic chicken IFN-γ in transgenic tobacco plants

  2009influential citation
• Use of oromucosally administered interferon-alpha in the prevention and treatment of animal diseases.

  2008cites this paper
• The Role of IFN-α as Homeostatic Agent in The Inflammatory Response: A Balance between Danger and Response?

  2007influential citation
• A novel AF10‐CALM fusion transcript in γ/δ‐T cell type lymphoblastic lymphoma

  2007cites this paper
• Effects of exogenous transforming growth factor beta on Trypanosoma congolense infection in mice.

  2007cites this paper
• Experience with oral interferon‐alpha in patients with essential thrombocythemia and polycythemia vera

  2007cites this paper
• Effects of Exogenous Transforming Growth Factor β on Trypanosoma congolense Infection in Mice

  2007cites this paper
• Rotavirus Infection Alters Peripheral T-Cell Homeostasis in Children with Acute Diarrhea

  2007cites this paper
• Pretreatment with feline interferon omega and the course of subsequent infection with feline herpesvirus in cats.

  2007cites this paper
• Imaging-guided gene therapy of experimental gliomas.

  2007cites this paper
• Evidence for the immunostimulatory effects of low-dose orally delivered human IFN-alpha in cattle.

  2006cites this paper
• Low-dose interferon-alpha treatment for feline immunodeficiency virus infection.

  2006influential citation
• Evidence for the Immunostimulatory Effects of Low-Dose Orally Delivered Human IFN-α in Cattle

  2006cites this paper
• Ability of Orally Administered IFN-α-Containing Transgenic Potato Extracts to Inhibit Listeria monocytogenes Infection

  2005cites this paper